Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates

Moderna (MRNA) Tops Q4 EPS by $1.54, Beats on Revenue, Reaffirms COVID-19 Vax Guidance

February 22, 2024 6:46 AM EST

(Updated - February 22, 2024 6:49 AM EST)

Moderna (NASDAQ: MRNA) reported Q4 EPS of $0.55, $1.54 better than the analyst estimate of ($0.99). Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.51 billion.

The Company is reaffirming its 2024... More